You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

QS-21

Showing 1 - 25 of 3,891
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Oslo (TG01)

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • TG01
  • Oslo, Norway
    Oslo Myeloma Center
May 2, 2023

Pancreas Cancer Trial in United States (TG01 Vaccine, QS-21, Balstilimab)

Recruiting
  • Pancreas Cancer
  • TG01 Vaccine
  • +2 more
  • Fairway, Kansas
  • +4 more
Jan 30, 2023

Neuroblastoma Trial in New York (dietary supplement, drug, biological)

Recruiting
  • Neuroblastoma
  • β-glucan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 5, 2022

Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)

Recruiting
  • Neuroblastoma
  • +2 more
  • OPT-821 (QS-21)
  • oral β-glucan
  • Basking Ridge, New Jersey
  • +6 more
Sep 21, 2023

Campylobacter Infection Trial in Cincinnati (ALFQ, CJCV2)

Not yet recruiting
  • Campylobacter Infection
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center - Infectious Disea
Aug 11, 2022

Solid Tumor, Adult Trial in Miami (ASV® AGEN2017 + QS-21 Stimulon® adjuvant)

Completed
  • Solid Tumor, Adult
  • ASV® AGEN2017 + QS-21 Stimulon® adjuvant
  • Miami, Florida
    School of Medicine at the University of Miami
Dec 1, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +3 more
Oct 28, 2021

HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and A244 rgp120/HIV-1
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 28, 2021

Herpes Simplex Type 2 Trial in Portland, Houston, Seattle (HerpV and QS-21, Placebo)

Completed
Has Results
  • Herpes Simplex Type 2
  • HerpV and QS-21
  • Placebo
  • Portland, Oregon
  • +4 more
Jun 22, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +4 more
Oct 28, 2021

SARS-CoV-2 Infection Trial in Silver Spring (25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant), Sodium chloride, USP, for injection

Active, not recruiting
  • SARS-CoV-2 Infection
  • 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)
  • +2 more
  • Silver Spring, Maryland
    WRAIR Clinical Trials Center
Sep 13, 2021

HIV Trial in Birmingham, Rochester, Seattle (rgp120/HIV-1MN)

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • Birmingham, Alabama
  • +2 more
Oct 27, 2021

Alzheimer Trial in France, Germany, Spain (ACC-001(3µg) + QS21, ACC-001(10µg) + QS21, ACC-001(30µg) + QS21)

Completed
Has Results
  • Alzheimer Disease
  • ACC-001(3µg) + QS21
  • +2 more
  • Bordeaux Cedex, France
  • +16 more
Mar 1, 2021

Breast Cancer Trial in New York (QS21, sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine, immunoenzyme technique)

Completed
Has Results
  • Breast Cancer
  • QS21
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 16, 2020

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

Polycythemia Vera Trial in Worldwide (Placebo, Rusfertide)

Recruiting
  • Polycythemia Vera
  • Fresno, California
  • +34 more
Jul 28, 2022

COPD Trial in Shenzhen (Intervention group, control group)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Intervention group
  • control group
  • Shenzhen, Guang Dong, China
    Shenzhen People's Hospital
Dec 16, 2022

Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Trial in Worldwide (FG-4592, Placebo)

Active, not recruiting
  • Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)
  • Los Angeles, California
  • +71 more
Sep 16, 2022

Human Immunodeficiency Virus (HIV), AIDS Virus Trial in Silver Spring (A244, B.63521, 50µg ALFQ)

Not yet recruiting
  • Human Immunodeficiency Virus (HIV)
  • AIDS Virus
  • A244
  • +4 more
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research, Clinical Trials Center
Jul 20, 2022

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

Neuroblastoma Trial in New York (adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH,

Active, not recruiting
  • Neuroblastoma
  • adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH
  • oral β-glucan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 11, 2021

Vaccine Reaction Trial in Silver Spring (FMP013, ALFQ)

Recruiting
  • Vaccine Reaction
  • Silver Spring, Maryland
    WRAIR, Clinical Trials Center
Apr 14, 2021

Vaccine Reaction Trial in Silver Spring (FMP014, ALFQ)

Recruiting
  • Vaccine Reaction
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research
Apr 14, 2021

Psychological Impact of COVID-19 on Intensive Care Survivors

Recruiting
  • COVID-19
  • +5 more
    • Truro, Cornwall, United Kingdom
    • +44 more
    Oct 26, 2021

    Multidimensional Assessment of Dyspnea in Asthma

    Terminated
    • Asthma
    • Questionnaire
    • Dunkerque, France
    • +4 more
    Jan 23, 2023